Abstract
Cancer is a serious life-threatening disease with increased morbidity and mortality in dogs. A number of cancers are diagnosed after metastasis has taken place when therapeutic intervention would have been useless. In view of this, mammary gland tumors and adenocarcinoma of the lungs were calculated using some established and revised formulas. The reported fundamental parameters were calculated using macroscopy. But the mathematical oncological analysis revealed that tumor doubling time (82.1–123.1 days) of adenocarcinoma of the lung was lower than that of complex mammary adenoma (101.3–151.9 days), complex carcinoma of the lung (215.5–323.2 days), and benign mammary gland tumor (810–1215 days), respectively, suggesting that adenocarcinoma of the lung proliferates faster than the remaining cancers. Cancer cells per year for adenocarcinoma (1.21 × 108), benign mammary gland tumor (1.35 × 109), complex mammary adenoma (1.4–3.3 × 108), and complex carcinoma of the lung (3.4 × 108) with benign mammary gland tumor metastasized and others were about to metastasize. Therefore, the formulas can be used in estimation of some oncological parameters such as tumor volume, tumor weight, and tumor doubling time. All the investigated tumors can be managed chemotherapeutically if detected early enough. However, adenocarcinoma of the lung may be proven very difficult to treat because of low tumor doubling, doubling time followed by complex mammary adenoma, and complex carcinoma of the lung. Hence, oncological parameters could serve as indices of successful therapeutic interventions.
Similar content being viewed by others
References
Abdallah BK, Rashid NG, Tawfiq SA (2018) Demographic features of neuroblastoma in Iraq- Kurdistan region-Sulaimani. Iraqi J Hematol 7:62–66
Adams MP, Koch RW (2010) Pharmacology connections to nursing practice. Pearson, New Jersey, p 1526
Albert RE, Benjamin SA, Shukla R (1994) Life span and cancer mortality in the beagle dog and humans. Mech Aging Dev 74(3):147–159
Altman DG (1992) Analysis of survival times in: practical statistics for medical research. Chapman and Hall, London, pp 365–393
Anisimov VN (1987) Carcinogenesis and aging. Vol. 1 & 2. CRC Press, Boca Raton
Anisimov VN (2002) The relationship between aging and carcinogesis: a critical appraisal. Crit Rev Oncol Hematol 45:277–304
Baade P, Youlden DR, Andersson TML, Youl PH, Kimlin MG, Aitken JF, Biggar RJ (2015) Estimating the change in life expectancy after a diagnosis of cancer among the Australian population. BMJ Open 5:1–7
Baker MJ, Gazi E, Brown MD, Shanks JH, Gardner P, Clarke NW (2008) FTIR – based spectroscopic analysis in the identification of clinically aggressive prostate. Cancer 99:1854–1866
Bellisola G, Sorio C (2012) Infrared spectroscopy and microscopy in cancer research and diagnosis. Am J Cancer Res 2(1):1–21
Bradley NL, Wiseman SM (2017) Papillary thyroid microcarcinoma: the significance of high risk features. BMC Cancer 17:1–5
Buffenstein R (2008) Distinct tumor suppressor mechanisms evolve in rodent species that differ in size and lifespan. Aging Cell 7:813–823
Burek JD, Hollander CF (1977) Incidence patterns of spontaneous tumors in BN/Bi rats. J Natl Cancer Inst 58:99–105
Campisi J (2005) Senescent cells, tumor suppression and organizational aging: good citizens, bad neighbors. Cell 120:513–522
Capocaccia R, Gatta G, Maso LD (2015) Life expectancy of colon, breast and testicular cancer patients: an analysis of US-SEER population based data. Ann Oncol 26:1263–1268
Chauviere AH, Hatzikirou H, Lowengrub JS, Frieboes HB, Thompson AM, Cristini V (2011) Mathematical oncology: how are the mathematical and physical sciences contributing to the war on breast cancer? Curr Breast Cancer Rep 2(3):121–129
Cizkova J, Cervinkova M (2015) Celiac disease and cancer-are there potential links? is the vigilance of immune system in celiac disease a doubleedged sword? Int J Celiac Dis 3(4):148–150
Coleman MP, Quaresma N, Berrino E, Lutz JM, Angelis RD, Capocaccia R, Baili P, Rachet B, Gatta, Hakulonen T, Micheli A, Sagt M, Weir HK, Edwood JM, Tsukuma H, Koifman SA, Azevedoe SG, Francisi S, Santaquilari W, Verderchia A, Storm HH, Young JL, Concord Working Group (2008) Cancer survival in five continents: a worldwide population-based study. Lancet Oncol 9:730–756
Cummings BS, Wills LP, Schnellmann RG (2004) Measurement of cell death in mammalian cells. Curr Prot Pharmacol. https://doi.org/10.1002/0471141755.ph1208s25
De Luca AC, Dholakia K, Mazilu M (2015) Modulated Raman spectroscopy for enhanced cancer diagnosis at the cellular level. Sensors 15:13680–13704
Dix D, Cohen P, Flannery J (1980) On the role of aging in cancer incidence. J Theor Biol 83:163–173
Dorm C-R (1967) The epidemiology of cancer in animals. California Med 107(6):481–489
Dubray B, Henry-Amar M, Meenwaldt JH, Noordijk EM, Dixon DO, Cosset JM, Thames HD (1995) Radiation-induced lung damage after thoracic irradiation for Hodgkin's disease: the role of fractionation. Radiother Oncol 36(3):211–217
Ferlay J, Shin HR, Bray E, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008. Int J Cancer 127:2893–2917
Fornvik D, Lang K, Andersson I, Dustler M, Borquist S, Timberg P (2016) Estimates of breast cancer growth rate from mammograms and its relation to tumor characteristics. Radiat Prot Dosim 169(1–4):151–157
Forrest LJ, Dodge RK, Page RL, Heidner GL, Mc Entee MC, Novotney CA, Thrall DE (1992) Relationship between quantitative tumor scintigraphy and time to metastasis in dogs with osteosarcoma. J Nuclear Med 33(8):1542–1547
Friberg S, Nystrom A (2015) Cancer metastasis: early dissemination and late recurrences. Cancer Growth Metastasis 8:43–49
Goel MK, Khanna P, Kishore J (2010) Understanding analysis: Kaplan-Meier estimate. Int J Ayurveda Res 1(4):274–278
Gorbunova V, Saluanov A, Zhang Z, Gladyshev VN and Vijg J (2014) Comparative genetics of longevity and cancer: insights from long-lived rodents
Guo K, Cai L, Zhang Y, Zhu JF, Rong TH, Lin P, Hao CY, Wang WP, Li Z and Zhang Li J (2012) The predictive value of histological tumor regression grading (TRG) for therapeutic evaluation in locally advanced esophageal carcinoma treated with neo-adjuvant chemotherapy
Hafen E, Stocker H (2003) How are the sizes of cells, organs and bodies controlled? PLoS Biol 1(3):319–323
Han JH, Kim KS, Kim JH (2016) Mammary gland tumors in three male dogs. Kor J Vet Res 56(4):292–232
Honda O, Nakamura H (2009) Doubling time of lung cancer determined using three-dimensional volumetric software: comparison of squamous cell carcinoma and adenocarcinoma. Lung Cancer 66(2):211–217
Kanashiki M, Tomizawa T, Yamuguchi I, Kurishona K, Hizawa N, Ishikawa H, Kagohashi K, Satih H (2012) Volume doubling time of lung cancers detected in a chest radiograph mass screening program: comparison with CT screening. Oncol Lett 4(3):513–516
Kor YG, Saeedan M, Sobei MSB (2017) Breast cancer arising from a suspected fibroadenoma during pregnancy: a case report and review of literature. J Cancer Sci Ther 9(8):589–592
Kotwal AA, Mohile SG, Dale W (2012) Remaining life expectancy measurement and PSA screening of older men. J Geriatr Oncol 3(3):196–204
Kristiansen VM, Devvi S, Horsberg TE, Jonasdotthir TJ, Moe L, Berlinger B, Lindkaer-Jensen S, Larsen S (2015) Tolerability and pharmacokinetic profile of a novel benzene-polycarboxylic acids complex with cis-diammineplatinum (11) dichloride in dogs with malignant mammary tumors. Vet Comp Oncol 15(1):118–132
Kuang Y, Nagy JD, Eikenberry SE (2016) Introduction to mathematical oncology. CRC Press, Boca Raton
Laird, A.K. (1965). British journal of Cancer 19: 278,
Lipinan R, Galecki A, Burke DT, Miller RA (2004) Genetic loci that influence cause of death in a heterogenous mouse stock. J Gentorol A Biol Sci Med Sci 59:977–983
Lodish H, Berk A, Zipursky SL, Matsudaira P, Baltimore D, Darnell J (2000) Molecular cell biology. W.H. Freeman & Co., New York
Mehrara E, Forssell-Aronsson E, Ahlman H, Bernhardt P (2007) Specific growth rate versus doubling time for quantitative characterization of tumor growth rate. Cancer Res 67(8):3493–3987
Mehrotra R, Ray B, Chaturvedi H (2016) Biochemical characterization of lung cancer tissue: a spectroscopic investigation. J Cancer Clin Oncol 2(1):1–8
Michor F, Beal K (2015) Improving cancer treatment via mathematical modelling: surmounting the challenges is worth the effort. Cell 163:1059–1063
Pacholczyk B, Fabianska A, Kusinka R, Potemski P, Kordek R, Jankowski S (2012) Analysis of cancer tissues by means of spectroscopic methods. Contemp Oncol (Pozn) 16(4):290–294
Parkin DM, Bray FI, Devesa SS (2001) Cancer burden in the year 2000. The global picture. Eur J Cancer 37:4–66
Pugnetti G (1980) Simon and Schuster’s Guide to Dogs. Simon and Schuster Inc., New York, p 447
Rai T, Kuroishi TY, Kurita Y, Naruke T, Kaneko M (1994) Tumor doubling time and prognosis in lung cancer patients: evaluation from chest films and clinical follow-up study. Jpn J Clin Oncol 24(4):199–204
Rajaraman R et al (2007) Telomere uncapping in progenitor cells with critical telomere shortening is coupled to S-phase progression in vivo. PNAS 104(45):17747–17752
Ramos IRM, Malkin A, Lyng FM (2015) Current advances in the application of raman spectroscopy for molecular diagnosis of cervical cancer. Biomed Res Int 12561242:1–9
Rowell JL, McCarthy DO, Alvarez CE (2011) Dog models of naturally occurring cancer. Trends Mol Med 17:380–388
Rich JT, Neely TG, Paniello RC, Voelker CCJ, Nussenbaum B, Wang EC (2010) A practical guide to understanding Kaplan-Meier curves. Otolaryngol Head Neck Surg 143(3):331–336
Ryu EB, Change JM, Seo M, Kim SA, Lim JH, Moon WK (2014) Tumor volume doubling time of molecular breast cancer cell types assessed by serial ultrasound. Eur Radiol 24(9):2227–2235
Saganuwan SA (2017) Derivation of a unique body surface area (bsa) formula for calculation of relatively safe doses of dog and human anticancer drugs. J Cancer Sci Ther 9(10):690–704
Saganuwan SA (2018). Relationship between body surface areas and encephalization quotient in chemotherapy of brain cancers: the functions of four modified formulas. Twelfth World Cancer Congress, July 23-25; Moscow, Russia 3: 4
Saganuwan SA, Ndakotsu AM (2015) Standardization and scoring of the body surface area (bsa) formulas for calculation of the doses of anticancer agents for cancer patients from the north-western Nigeria. J Cancer Sci Ther 7(1):012–018
Sannachi L, Tadayyon H, Sadeghi-Naini A, Tan W, Gandhi S, Wright F, Oelze M, Czarnota G (2015) Non-invasive evaluation of breast cancer response to chemotherapy using quantitative ultrasonic backscatter parameters. Med Image Anal 20:224–236
Seluanov A, Chen Z, Hine C, Sasahara THC, Ribeiro AACM, Catania KC, Presgraves DC, Gorbunova V (2007) Telomerase activity coevolves with body mass not lifespan. Ageing Cell 6:45–52
Skipper HE, Perry S (1970) Kinetics of normal and leukemic leukocyte populations and relevance to chemotherapy. 30(6):1883–1897
Soerjomataram L, Lortet-Tieulent J, Parkin DM, Ferlay J, Mathers C, Forman D, Bray F (2012) Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet 380:1840–1850
Stadtlander CTKH (2017) Introduction to mathematical oncology 10(1):501–505
Tacutu R, Craig T, Budovsky A, Wuttke D, Lehmann G, Taranukha D, Costa J, Fraifeld VE, de Magalhaes JP (2013) Human ageing genomic resources: integrated databases and tools for the biology and genetics of ageing. Nucleic Acids Res 41:1–7
Tait SWG, Green DR (2008) Caspace independent cell death: leaving the set without the final cut. Oncogene 27(50):6452–6461
Tubiana M, Pejovic MH, Koscielny S, Chavaudra N, Malaise E (1989) Growth rate, kinetics of tumor cell proliferation and long- term outcome in human breast cancer. Int J Cancer 44(1):17–22
Walker, Whittlesea C (2012) Clinical pharmacy and therapeutics, 5th edn. Churchill Livingstone, Elsevier, Philadelphia, p 983
Werahera PN, Glide M, LA Rosa FG, Lucia MS, Crawford ED, Easterday K, Sullivan HT, Sidhu RS, Genova E, Hedlund T(2011) Proliferative tumor doubling times of prostatic carcinoma. Prost Cancer. ID301850
Wilson DO, Ryan A, Fuhrman C, Schuchert M, Sairo S, Siegfried JM, Weissfeld J (2012) Doubling times and CT screen-detected lung cancers in the Pittsburg lung screening study. Am J Crit Care Med 185(1):85–89
Zar JH (2008) Biostatistical analysis, 4th edn. Pearson Education, Inc., New Delhi, p 663
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declares that there is no conflict of interest
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Saganuwan, S.A. Mathematical determination of some oncological parameters and their therapeutic implications in dogs. Comp Clin Pathol 28, 1025–1030 (2019). https://doi.org/10.1007/s00580-018-2874-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00580-018-2874-3